Gerald Linette

Member, Scientific Advisory Board at Argos Therapeutics, Inc.

Gerald Linette

Gerald Linette

Member, Scientific Advisory Board at Argos Therapeutics, Inc.

Biography

Dr. Linette earned his MD/PhD in microbiology from Georgetown University School of Medicine and is currently Professor of Medicine at the Hospital of the University of Pennsylvania, where he also serves as Chief Medical Officer for Cancer Immunotherapy and Clinical Director of the Sean Parker Institute. Dr. Linette is a member of the American Society of Clinical Oncology, American Society of Hematology, American Association of Immunologists, and American Association for Cancer Research. His primary interest is human cancer immunology.

Overview
RelSci Relationships

34

Number of Boards

1

Relationships
RelSci Relationships are individuals Gerald Linette likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at Argos Therapeutics, Inc.

Relationship likelihood: Strong

Co-Director, Cancer Immunotherapy Program at Columbia University Medical Center

Relationship likelihood: Strong

Member, Scientific Advisory Board at Argos Therapeutics, Inc.

Relationship likelihood: Strong

Chief of Strategy, Business Development & Outreach at Roswell Park Comprehensive Cancer Center

Relationship likelihood: Strong

Founder at Agensys, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at UbiVac LLC

Relationship likelihood: Strong

Chief Scientific Officer & Vice President, Research & Development at Argos Therapeutics, Inc.

Relationship likelihood: Average

Vice President, Finance & Chief Accounting Officer at Argos Therapeutics, Inc.

Relationship likelihood: Average

Chief Financial Officer, Vice President & Investor Relations Contact at Argos Therapeutics, Inc.

Relationship likelihood: Average

Chief Operating Officer at Argos Therapeutics, Inc.

Relationship likelihood: Average

Paths to Gerald Linette
Potential Connections via
Relationship Science
You
Gerald Linette
Member, Scientific Advisory Board at Argos Therapeutics, Inc.
Boards & Committees
Member, Scientific Advisory Board
Current

Argos Therapeutics, Inc. is a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and is headquartered in Durham, NC.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gerald Linette. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gerald Linette's profile does not indicate a business or promotional relationship of any kind between RelSci and Gerald Linette.